NewcelX (NCEL) Stock Analysis
NASDAQHealthcareBiotechnology
What NewcelX does
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
Key metrics
ETFs linked to NCEL
Broad-market and Healthcare sector ETFs an investor holding NewcelX is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how NCEL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze NCEL in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for NewcelX?
- NewcelX trades under the ticker NCEL on NASDAQ.
- Which exchange is NCEL listed on?
- NCEL is listed on NASDAQ.
- What sector does NewcelX operate in?
- NewcelX is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze NCEL in a portfolio?
- PortView shows NCEL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.